Collaboration between the neurologist and palliative care team in the care of patients with severe demyelinating disease can result in improved patient care, and discussion of the complex ethical issues that arise when a patient expresses a wish to die may be rewarding for both patients and caregivers.
Address correspondence to Professor Ludo J. Vanopdenbosch, Department of Neurology, AZ Sint Jan, Ruddershove 10, Brugge 8000, Belgium, email@example.com.
Relationship Disclosure: Dr Vanopdenbosch serves on the advisory boards of and has received personal compensation for speaking engagements from Biogen; Merck & Co, Inc; Novartis AG; and Sanofi Genzyme. Dr Oliver serves on the editorial board of the European Journal of Palliative Care, on the board of directors of the European Association of Palliative Care, and as chair of the Palliative Care Scientific Panel of the European Academy of Neurology. Dr Oliver has received paid travel accommodations/meeting expenses from the European Association of Palliative Care and for speaking engagements at conferences, including the Association of Palliative Medicine of Great Britain and Ireland, European Academy of Neurology, Finnish Palliative Care Society, Italian Society of Neurology, Motor Neurone Disease Association of Australia, and World Congress of Neurology. Dr Oliver receives royalties from Oxford University Press, Sheldon Press, and Springer and research support from the Motor Neurone Disease Association of England and Wales. Dr Kass has received personal compensation for expert testimony in legal cases involving personal injury, defamation, and malpractice.
Unlabeled Use of Products/Investigational Use Disclosure: Drs Vanopdenbosch, Oliver, and Kass report no disclosures.